Skip to main content

A decorative image.

Common Fund Programs with Open Funding Opportunities

Expand All to search section using Ctrl+F |
Human Virome Program
TitleNIH GuideRFA NumberCommon Fund ContactApplication Receipt Window
Notice of Special Interest (NOSI): Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed)10/23/2024RFA-RM-24-009Amanda Melillo
[email protected]
301-529-7217
Letter of Intent: 1/27/2025 Receipt Date: 2/27/2025
High-Risk Research: NIH Director's New Innovator Award Program
TitleNIH GuideRFA NumberCommon Fund ContactApplication Receipt Date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)11/16/2020PA-23-189Patricia (Trish) Labosky
[email protected]
 
High-Risk Research: NIH Director's Pioneer Award Program
TitleNIH GuideRFA NumberCommon Fund ContactApplication Receipt Date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)11/16/2020PA-23-189Patricia (Trish) Labosky
[email protected]
 
High-Risk Research: NIH Director's Transformative Award Program
TitleNIH GuideRFA NumberCommon Fund ContactApplication Receipt Date
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)11/16/2020PA-23-189Patricia (Trish) Labosky
[email protected]
 
Venture Program
TitleNIH GuideRFA NumberCommon Fund ContactApplication Receipt Date
In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed)12/02/2024RFA-RM-24-012Jonathan Pollock
[email protected] 
03/07/2025
Complement-ARIE Program
TitleRelease Date Funding Announcement NumberCommon Fund ContactLOI Due DateApplication
Receipt Date
Complement-ARIE New Approach Methodologies (NAMs) Data Hub and Coordinating Center (U24 Clinical Trial Optional)01/07/2025RFA-RM-24-013Daniel Shaughnessy
[email protected]
984-287-3321
02/10/202503/10/2025 by 5:00 PM local time of applicant organization
Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional)12/10/2024RFA-RM-24-010Danilo A. Tagle, Ph.D.
[email protected] 
240-418-5017

Christine Happel, Ph.D.
[email protected]
240-472-7550
1/24/20252/28/2025 by 5:00 PM local time of applicant organization

 

This page last reviewed on January 7, 2025